Company: SXTPW
Filing Date: 2025-02-06
Form Type: 424B5
Source: 0001213900-25-010772
Chunk: 79

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-06
Form: 424B5
Chunk 79
---
 if any, will be payable; |

| ● | the                                                                      
 redemption rights and price or prices, if any, for shares of the series; |

| ● | the                                                                                                    
 terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series; |

| ● | the                                                                                                                                
 amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the 
 affairs of our Company;                                                                                                            |

<div align='center'>21</div>

| ● | whether                                                                                                                             
 the shares of the series will be convertible into shares of any other class or series, or any other security, of our Company or any 
 other entity, and, if so, the specification of the other class or series or other security, the conversion price or prices or rate  
 or rates and provisions for any adjustments to such prices or rates, the date or dates as of which the shares will be convertible,  
 and all other terms and conditions upon which the conversion may be made;                                                           |

| ● | the                                                                                                                                   
 ranking of such series with respect to dividends and amounts payable on our liquidation, dissolution or winding-up, which may include 
 provisions that such series will rank senior to our common stock with respect to dividends and those distributions;                   |

| ● | restrictions                                                                  
 on the issuance of shares of the same series or any other class or series; or |

| ● | voting                                        
 rights, if any, of the holders of the series. |

The issuance of preferred stock could adversely affect, among other things, the voting power of holders of common stock and the likelihood that stockholders will receive dividend payments and payments upon our liquidation, dissolution or winding up. The issuance of preferred stock could also have the effect of delaying, deferring or preventing a change in control of us.

Section 203 of the Delaware General Corporation Law

We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. This statute prevents certain Delaware corporations, under certain circumstances, from engaging in a “business combination” with:

| ● | a                                                                                                                  
 stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an “interested stockholder”); |

| ● | an                                         
 affiliate of an interested stockholder; or |

| ● | an                                                                                                                                
 associate of an interested stockholder, for three years following the date that the stockholder became an interested stockholder. |

A “business combination” includes a merger or sale of